• Ownership

Kevin Fitzgerald - Insider Trading & Ownership

Entity
Individual
Location
C/O Ovid Therapeutics Inc., 1460 Broadway, Suite 15044, New York, NY
Summary
The estimated net worth of Kevin Fitzgerald is at least $3.41M dollars as of March 5, 2025. Kevin Fitzgerald is the CSO & EVP, Head of Research of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $3.41M.
All Insider Reports
All Insider Reports

Ownership of Kevin Fitzgerald

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALNY ALNYLAM PHARMACEUTICALS, INC. CSO & EVP, Head of Research $3.41M -$8.32M -70.9% Mar 3, 2025
OVID Ovid Therapeutics Inc. Director Dec 12, 2024

Insider Transactions Reported by Kevin Fitzgerald:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.